4 Key Takeaways:
- There are various ways to measure minimal disease activity in psoriatic arthritis to assess how the disease impacts quality of life.
- Attaining and keeping minimal disease activity low through use of different therapy options offers a chance for better bone and joint outcomes.
- Advancements in psoriatic arthritis include attaining ACR90 and the potential for identifying key markers that make treatment selection more targeted and individualized.
- Those who have psoriasis need to realize bone and joint pain, and swelling in the joints may be related to their psoriatic skin disease and seek appropriate help.